How L’Occitane’s Dr Vranjes Firenze aims to grow in Australia and beyond
Inside Retail
FEBRUARY 25, 2024
L’Occitane also acquired a 50 per cent stake in Singaporean skincare brand Erborian in 2012. Rebollini said that Dr Vranjes Firenze has outperformed the category since launching in the Australian market five months ago and that customer feedback suggests the brand is resonating with local shoppers.
Let's personalize your content